Share:
Peer-Reviewed Publication
J Clin Microbiol2025;63(5):e0185224.May 14, 2025Journal Article

Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study.

Valentina Milanova1, Michelle Gomes1, Kalina Mihaylova1, John Luke Twelves2, Jan Multmeier3, Hana McMahon4, Hannah McCulloch5, Kate Cuschieri4
1Daye, London, United Kingdom.
2Lindus Health, London, United Kingdom.
3TotaEffects GmH, Oranienburg, Germany.
4Center for Reproductive Health, University of Edinburgh, Edinburgh, Scotland, United Kingdom.
5Independent consultant, London, United Kingdom.

Abstract

Cervical cancer screening is vital for achieving global elimination of this preventable disease. Vaginal self-sampling (VSS) for human papillomavirus (HPV) has the potential to increase screening uptake, particularly among individuals who may be underserved by clinician collection. Expanding self-sampling options with accurate, acceptable collection devices is essential. The Daye diagnostic tampon…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.